Cargando…
AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors
The co-expression of androgen (AR) and estrogen (ER) receptors, in terms of higher AR/ER ratio, has been recently associated with poor outcome in ER-positive (ER+) breast cancer (BC) patients. The aim of this study was to analyze if the biological aggressiveness, underlined in ER+ BC tumors with hig...
Autores principales: | Rangel, Nelson, Rondon-Lagos, Milena, Annaratone, Laura, Aristizábal-Pachon, Andrés Felipe, Cassoni, Paola, Sapino, Anna, Castellano, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226480/ https://www.ncbi.nlm.nih.gov/pubmed/32344660 http://dx.doi.org/10.3390/cells9041064 |
Ejemplares similares
-
FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
por: Rangel, Nelson, et al.
Publicado: (2018) -
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes
por: Rondón-Lagos, Milena, et al.
Publicado: (2016) -
Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling
por: Villegas, Victoria E., et al.
Publicado: (2016) -
Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling
por: Annaratone, Laura, et al.
Publicado: (2013) -
FISH Diagnostic Assessment of MDM2 Amplification in Liposarcoma: Potential Pitfalls and Troubleshooting Recommendations
por: Gambella, Alessandro, et al.
Publicado: (2023)